Pregnancy labeling changes
Executive Summary
FDA's Reproductive Health Drugs/Pregnancy Labeling Subcommittee will meet to discuss possible changes to pregnancy labeling on June 6. FDA held a public hearing in September 1997 to discuss pregnancy classifications used in prescription drug labeling ("The Pink Sheet" July 26, 1998, p. 10). The committee will meet at 8 a.m. at the Holiday Inn in Silver Spring, Md